First Trust Advisors’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$109M Buy
2,534,992
+970,144
+62% +$41.7M 0.08% 318
2025
Q4
$68.6M Buy
1,564,848
+127,871
+9% +$5.29M 0.05% 440
2025
Q3
$59.3M Sell
1,436,977
-433,151
-23% -$17.4M 0.04% 502
2025
Q2
$82.4M Sell
1,870,128
-112,620
-6% -$4.5M 0.07% 363
2025
Q1
$73.2M Sell
1,982,748
-557,115
-22% -$19.9M 0.06% 380
2024
Q4
$84.6M Sell
2,539,863
-328,754
-11% -$10.7M 0.07% 332
2024
Q3
$74.4M Buy
2,868,617
+282,350
+11% +$7.02M 0.07% 328
2024
Q2
$58.1M Sell
2,586,267
-387,315
-13% -$8.59M 0.06% 381
2024
Q1
$70.6M Sell
2,973,582
-179,173
-6% -$3.98M 0.07% 336
2023
Q4
$75.6M Buy
3,152,755
+492,613
+19% +$10.7M 0.08% 308
2023
Q3
$58.1M Sell
2,660,142
-1,395,960
-34% -$29.2M 0.07% 384
2023
Q2
$77.5M Sell
4,056,102
-696,632
-15% -$13.4M 0.09% 310
2023
Q1
$92.3M Buy
4,752,734
+924,189
+24% +$16.1M 0.11% 251
2022
Q4
$61.4M Buy
3,828,545
+182,299
+5% +$2.97M 0.07% 399
2022
Q3
$57.2M Buy
3,646,246
+384,054
+12% +$7.42M 0.07% 415
2022
Q2
$67.9M Sell
3,262,192
-300,161
-8% -$6.19M 0.08% 356
2022
Q1
$80.8M Buy
3,562,353
+835,621
+31% +$16.3M 0.08% 324
2021
Q4
$49.8M Sell
2,726,732
-955,947
-26% -$18.3M 0.05% 503
2021
Q3
$77.9M Buy
3,682,679
+513,866
+16% +$9.54M 0.08% 301
2021
Q2
$57.7M Sell
3,168,813
-339,161
-10% -$7.91M 0.06% 434
2021
Q1
$79.2M Buy
3,507,974
+158,831
+5% +$3.59M 0.1% 276
2020
Q4
$67.2M Sell
3,349,143
-619,460
-16% -$13M 0.09% 301
2020
Q3
$97M Sell
3,968,603
-362,635
-8% -$8.47M 0.16% 154
2020
Q2
$103M Sell
4,331,238
-635,902
-13% -$14.7M 0.18% 137
2020
Q1
$85.5M Buy
4,967,140
+568,921
+13% +$10.4M 0.19% 119
2019
Q4
$77.5M Buy
4,398,219
+373,013
+9% +$6.32M 0.13% 190
2019
Q3
$71.2M Sell
4,025,206
-1,840,431
-31% -$37.2M 0.13% 194
2019
Q2
$125M Buy
5,865,637
+433,202
+8% +$9.08M 0.24% 82
2019
Q1
$129M Sell
5,432,435
-118,703
-2% -$2.71M 0.26% 77
2018
Q4
$109M Buy
5,551,138
+907,412
+20% +$16.2M 0.26% 63
2018
Q3
$82.3M Buy
4,643,726
+2,044,201
+79% +$39.9M 0.15% 150
2018
Q2
$55.9M Buy
2,599,525
+1,726,507
+198% +$35.7M 0.12% 186
2018
Q1
$19.3M Buy
873,018
+237,256
+37% +$6.56M 0.04% 569
2017
Q4
$19.3M Sell
635,762
-450,373
-41% -$12M 0.05% 560
2017
Q3
$26.3M Buy
1,086,135
+928,475
+589% +$24.7M 0.07% 363
2017
Q2
$3.88M Sell
157,660
-7,243
-4% -$153K 0.01% 1118
2017
Q1
$3.57M Sell
164,903
-5,847
-3% -$119K 0.01% 1180
2016
Q4
$2.55M Sell
170,750
-90,624
-35% -$1.31M 0.01% 1296
2016
Q3
$3.34M Buy
261,374
+178,199
+214% +$1.93M 0.01% 1113
2016
Q2
$650K Buy
+83,175
New +$479K ﹤0.01% 1882

Other funds holding EXEL

First Trust Advisors's EXEL Position: Q1 2026 in Review

First Trust Advisors increased its Exelixis (EXEL) stake by 62% in Q1 2026, buying an estimated $41.7M and bringing the position to 2,534,992 shares worth $109M. The position accounts for 0.08% of the portfolio, ranked #318.

First Trust Advisors first reported a position in EXEL in Q2 2016 and has held it in 40 quarters since. The position peaked at $129M in Q1 2019. 694 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.

  • First Trust Advisors held 2,534,992 shares of Exelixis worth $109M as of Q1 2026.
  • First Trust Advisors bought 970,144 Exelixis shares in Q1 2026, an estimated $41.7M.
  • Exelixis made up 0.08% of First Trust Advisors's portfolio in Q1 2026, its #318 holding.
  • First Trust Advisors first reported a position in Exelixis in Q2 2016 and has held it in 40 quarters since.
  • First Trust Advisors's Exelixis position peaked at $129M in Q1 2019.
  • 694 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.

Based on First Trust Advisors's 13F filing for Q1 2026, filed 13 May 2026.